These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 25188033)

  • 1. Venlafaxine and O-desmethylvenlafaxine concentrations in plasma and cerebrospinal fluid.
    Paulzen M; Groppe S; Tauber SC; Veselinovic T; Hiemke C; Gründer G
    J Clin Psychiatry; 2015 Jan; 76(1):25-31. PubMed ID: 25188033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Venlafaxine: the relationship between dose, plasma concentration and clinical response in depressive patients.
    Charlier C; Pinto E; Ansseau M; Plomteux G
    J Psychopharmacol; 2002 Dec; 16(4):369-72. PubMed ID: 12503838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of the Proton Pump Inhibitors Omeprazole and Pantoprazole on the Cytochrome P450-Mediated Metabolism of Venlafaxine.
    Kuzin M; Schoretsanitis G; Haen E; Stegmann B; Hiemke C; Gründer G; Paulzen M
    Clin Pharmacokinet; 2018 Jun; 57(6):729-737. PubMed ID: 28866861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concentrations of venlafaxine and its main metabolite O-desmethylvenlafaxine during pregnancy.
    ter Horst PG; Larmené-Beld KH; Bosman J; van der Veen EL; Wieringa A; Smit JP
    J Clin Pharm Ther; 2014 Oct; 39(5):541-4. PubMed ID: 24989434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Marked increase of venlafaxine enantiomer concentrations as a consequence of metabolic interactions: a case report.
    Eap CB; Bertel-Laubscher R; Zullino D; Amey M; Baumann P
    Pharmacopsychiatry; 2000 May; 33(3):112-5. PubMed ID: 10855463
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The pharmacokinetics of venlafaxine when given in a twice-daily regimen.
    Troy SM; Parker VD; Fruncillo RJ; Chiang ST
    J Clin Pharmacol; 1995 Apr; 35(4):404-9. PubMed ID: 7650231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum concentrations of venlafaxine and its metabolites O-desmethylvenlafaxine and N-desmethylvenlafaxine in heterozygous carriers of the CYP2D6*3, *4 or *5 allele.
    Hermann M; Hendset M; Fosaas K; Hjerpset M; Refsum H
    Eur J Clin Pharmacol; 2008 May; 64(5):483-7. PubMed ID: 18214456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antidepressant polypharmacy and the potential of pharmacokinetic interactions: Doxepin but not mirtazapine causes clinically relevant changes in venlafaxine metabolism.
    Paulzen M; Haen E; Hiemke C; Fay B; Unholzer S; Gründer G; Schoretsanitis G
    J Affect Disord; 2018 Feb; 227():506-511. PubMed ID: 29156365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Steady-state concentration of venlafaxine enantiomers: model-based analysis of between-patient variability.
    Gex-Fabry M; Rudaz S; Balant-Gorgia AE; Brachet A; Veuthey JL; Balant LP; Bertschy G
    Eur J Clin Pharmacol; 2002 Aug; 58(5):323-31. PubMed ID: 12185556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and tolerability of venlafaxine in geriatric outpatients with major depression: a double-blind, randomised 6-month comparative trial with citalopram.
    Allard P; Gram L; Timdahl K; Behnke K; Hanson M; Søgaard J
    Int J Geriatr Psychiatry; 2004 Dec; 19(12):1123-30. PubMed ID: 15526307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum and Saliva Concentrations of Venlafaxine, O-Desmethylvenlafaxine, Quetiapine, and Citalopram in Psychiatric Patients.
    Ebert K; Maurice E; Lukačin R; Fleischhaker C; Schulz E; Ebert D; Clement HW
    Ther Drug Monit; 2018 Jun; 40(3):351-355. PubMed ID: 29746434
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A simple HPLC method for the simultaneous determination of venlafaxine and its major metabolite O-desmethylvenlafaxine in human serum.
    Samanidou V; Nazyropoulou C; Kovatsi L
    Bioanalysis; 2011 Aug; 3(15):1713-8. PubMed ID: 21827270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CYP2D6 genotype and venlafaxine-XR concentrations in depressed elderly.
    Whyte EM; Romkes M; Mulsant BH; Kirshne MA; Begley AE; Reynolds CF; Pollock BG
    Int J Geriatr Psychiatry; 2006 Jun; 21(6):542-9. PubMed ID: 16642541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of ketoconazole on venlafaxine plasma concentrations in extensive and poor metabolisers of debrisoquine.
    Lindh JD; Annas A; Meurling L; Dahl ML; AL-Shurbaji A
    Eur J Clin Pharmacol; 2003 Sep; 59(5-6):401-6. PubMed ID: 12898080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Desvenlafaxine: another "me too" drug?
    Sopko MA; Ehret MJ; Grgas M
    Ann Pharmacother; 2008 Oct; 42(10):1439-46. PubMed ID: 18698015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maternal use of venlafaxine near term: correlation between neonatal effects and plasma concentrations.
    Boucher N; Koren G; Beaulac-Baillargeon L
    Ther Drug Monit; 2009 Jun; 31(3):404-9. PubMed ID: 19455083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Introduction of a composite parameter to the pharmacokinetics of venlafaxine and its active O-desmethyl metabolite.
    Klamerus KJ; Maloney K; Rudolph RL; Sisenwine SF; Jusko WJ; Chiang ST
    J Clin Pharmacol; 1992 Aug; 32(8):716-24. PubMed ID: 1487561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The influence of cimetidine on the disposition kinetics of the antidepressant venlafaxine.
    Troy SM; Rudolph R; Mayersohn M; Chiang ST
    J Clin Pharmacol; 1998 May; 38(5):467-74. PubMed ID: 9602962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytochrome P450 2D6 phenoconversion is common in patients being treated for depression: implications for personalized medicine.
    Preskorn SH; Kane CP; Lobello K; Nichols AI; Fayyad R; Buckley G; Focht K; Guico-Pabia CJ
    J Clin Psychiatry; 2013 Jun; 74(6):614-21. PubMed ID: 23541126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Employing atmospheric pressure photoionization in liquid chromatography/tandem mass spectrometry to minimize ion suppression and matrix effects for the quantification of venlafaxine and O-desmethylvenlafaxine.
    Theron HB; van der Merwe MJ; Swart KJ; van der Westhuizen JH
    Rapid Commun Mass Spectrom; 2007; 21(10):1680-6. PubMed ID: 17465011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.